alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
September 13, 1999

Joseph Dillon & Company, Inc.      Continental Stock Transfer & Trust Company
107 Northern Boulevard             2 Broadway
Great Neck, New York 11021         New York, New York 10004

    RE:  Amendment No. 2 to Warrant Agreement

Gentlemen:

     This letter agreement represents Amendment No. 2 to the Warrant Agreement
between Joseph Dillon & Company, Inc. ("Dillon"), Continental Stock Transfer
& Trust Company (the "Warrant Agent"), and Dialysis Corporation of America
(the "Company"), dated April 16, 1996, between and among the parties, and
amended on March 9, 1999 (the "Warrant Agreement"), to further extend the
exercise period of the Warrants to March 31, 2000.  This Amendment No. 2
amends Section 2 of the Warrant Agreement as amended on March 9, 1999 by
extending the exercise period of the Warrants to March 31, 2000.  Any and
all other provisions of the Warrant Agreement indicating the expiration of
the term being October 16, 1999 are hereby amended to read March 31, 2000.

     The Warrants and the Warrant Agreement as previously modified will
otherwise remain the same and in full force and effect in accordance with
their terms.

                                       Very truly yours,

                                       DIALYSIS CORPORATION OF AMERICA

                                          /s/ Thomas K. Langbein

                                       By:--------------------------------
                                          THOMAS K. LANGBEIN, Chief
                                          Executive Officer

                                       Dated: September 10, 1999

Acknowledged and agreed to:

Joseph Dillon & Company, Inc.       Continental Stock Transfer & Trust Company

   /s/ Steven Jaloza                   /s/ William F. Seegraber, Vice President

By:-------------------------------- By:------------------------------------
   STEVEN JALOZA, CEO                  William F. Seegraber, Vice President

Dated: September 10, 1999           Dated: September 10, 1999
#### Richard Henry MUTCH, Plaintiff-Appellant, v. UNITED STATES, Defendant-Appellee.

No. 2007-5117.

United States Court of Appeals, Federal Circuit.

Dec. 12, 2007.

Richard H. Mutch, pro se.

ORDER

The appellant having failed to pay the docketing fee required by Federal Circuit Rule 52(a)(1) within the time permitted by the rules, it is

ORDERED that the notice of appeal be, and the same hereby is, DISMISSED, for failure to prosecute in accordance with the rules.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF RIVERWOOD HOLDING FOR THE THREE MONTHS ENDED MARCH 31,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          16,280
<SECURITIES>                                         0
<RECEIVABLES>                                  159,992
<ALLOWANCES>                                     3,137
<INVENTORY>                                    173,306
<CURRENT-ASSETS>                               362,105
<PP&E>                                       1,407,927
<DEPRECIATION>                                 485,930
<TOTAL-ASSETS>                               2,341,399
<CURRENT-LIABILITIES>                          274,774
<BONDS>                                      1,706,192
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            75
<OTHER-SE>                                     252,610
<TOTAL-LIABILITY-AND-EQUITY>                 2,341,399
<SALES>                                        270,229
<TOTAL-REVENUES>                               270,229
<CGS>                                          211,928
<TOTAL-COSTS>                                  211,928
<OTHER-EXPENSES>                                34,205
<LOSS-PROVISION>                                  (363)
<INTEREST-EXPENSE>                              45,771
<INCOME-PRETAX>                                (21,503)
<INCOME-TAX>                                     1,071
<INCOME-CONTINUING>                            (21,163)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (21,163)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Leo Ehrlich, Chief Financial Officer of Saliva Diagnostic Systems, Inc.,
hereby certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002:


(1)   that the Quarterly Report on Form 10-QSB of Saliva Diagnostic Systems,
      Inc. for the quarterly period ended on March 31, 2005 filed with the
      Securities and Exchange Commission on the date hereof at File No. 0-21284
      (the "Report") fully complies with the requirements of Section 13(a) or
      15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)   that the information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of
      Saliva Diagnostic Systems, Inc.


Dated:  July 8, 2005
                              /s/ Leo Ehrlich
                              -----------------------
                              Leo Ehrlich
                              Chief Financial Officer
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

________________

NO. 09

- 1 8

- 00 349

- CR

________________

EX PARTE HOMERO HERNANDEZ BOLANOS

__________________________________________________________________

On Appeal from the 3 5 9th District Court

Montgomery County, Texas

Trial Cause No. 08

- 05

- 04386

- CR

__________________________________________________________________

MEMORANDUM OPINION

Homero Hernandez Bolanos has filed a motion to dismiss his appeal. See Tex.

R. App. P. 42.2. A request to dismiss the appeal is signed by Bolanos personally and

joined by counsel of record. No opinion has issued in this appeal. The motion is

granted, and t he appeal is therefore dismissed.

DISMISS ED.

______________________________ STEVE McKEITHEN

Chief Justice2 Submitted on February 5, 2019

Opinion Delivered February 6, 2019

Do Not Publish

Before McKeithen, C.J., Kreger and Horton , JJ

.
**EXHIBIT 99.2**

 

**CERTIFICATIONS**

 

In connection with the annual report of Repsol Oil & Gas Canada Inc. (the “Company”) on Form 40-F for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Luis Cabra Dueñas, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.                                      The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                                      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

February 26, 2016

 
| By:    | /s/ LUIS CABRA DUEÑAS |   |
|--------|----------------------------|--------|
| Name:  | Luis Cabra Dueñas     |   |
| Title: | Chief Executive Officer    |   |

 

1

----

 

**CERTIFICATIONS**

 

In connection with the annual report of Repsol Oil & Gas Canada Inc. (the “Company”) on Form 40-F for the fiscal year ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Newby, Senior Vice-President, Finance, Treasurer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.                                      The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                                      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

February 26, 2016

 
| By:    | /s/ DAVID NEWBY                                                            |   |
|--------|----------------------------------------------------------------------------|--------|
| Name:  | David Newby                                                                |   |
| Title: | Senior Vice-President,   Finance, Treasurer    and Chief Financial Officer |   |

 

2

----
**EXHIBIT 32.1**

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

In connection withthe Annual Report of NATIONAL TECHNICAL SYSTEMS, INC. (the “Company”) on Form 10-Kfor the period ending January 31, 2006 as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, William Mc Ginnis,Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, tomy knowledge:

(1)          The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934, as amended; and

(2)          Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

| Dated: April 28, 2006 | /s/ WILLIAM MCGINNIS             |
|----------------------------|----------------------------------|
|                       | William McGinnis,                |
| * *                   | *Chief  Executive Officer*       |
| * *                   | *and  Director*                  |
| * *                   | *(Principal  Executive Officer)* |

 

A signed original of this written statement requiredby Section 906 has been provided to the Company and will be retained bythe Company and furnished to the Securities and Exchange Commission or itsstaff upon request.

----
II 

114TH CONGRESS 

1ST SESSION S. 554 

To provide for the compensation of Federal employees affected by a lapse 

in appropriations. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 24, 2015 

Mr. CARDIN (for himself, Ms. MIKULSKI, Mr. UDALL, Mr. LEAHY, Mrs. 

GILLIBRAND, Mr. KAINE, Mrs. BOXER, Mr. BLUMENTHAL, Mr. WARNER, 

Mr. SANDERS, Mr. CARPER, Mrs. MURRAY, Ms. BALDWIN, and Ms. 

HIRONO) introduced the following bill; which was read twice and referred 

to the Committee on Homeland Security and Governmental Affairs 

A BILL 

To provide for the compensation of Federal employees 

affected by a lapse in appropriations. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Federal Employee Ret5 roactive Pay Fairness Act of 2015’’. 

6 SEC. 2. COMPENSATION FOR FEDERAL EMPLOYEES AF7 FECTED BY A LAPSE IN APPROPRIATIONS. 

8 (a) DEFINITIONS.—In this section— 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•S 554 IS

1 (1) the term ‘‘covered lapse in appropriations’’ 

2 means the lapse in appropriations that begins on or 

3 about February 28, 2015; and 

4 (2) the term ‘‘excepted employee’’ means an ex5 cepted employee or an employee performing emer6 gency work, as such terms are defined by the Office 

7 of Personnel Management. 

8 (b) COMPENSATION FOR EMPLOYEES.—Each Fed9 eral employee furloughed as a result of the covered lapse 

10 in appropriations shall be paid for the period of the lapse 

11 in appropriations, and each excepted employee who is re12 quired to perform work during the covered lapse in appro13 priations shall be paid for such work, at the employee’s 

14 standard rate of pay at the earliest date possible after the 

15 lapse in appropriations ends, regardless of scheduled pay 

16 dates. 

17 (c) LEAVE FOR EXCEPTED EMPLOYEES REQUIRED

18 TO PERFORM WORK.—Notwithstanding subchapter III of 

19 chapter 13 of title 31, United States Code, during the cov20 ered lapse in appropriations, each excepted employee who 

21 is required to perform work shall be entitled to use leave 

22 under chapter 63 of title 5, United States Code, or any 

23 other applicable law governing the use of leave by the ex24 cepted employee, for which compensation shall be paid at 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•S 554 IS

1 the earliest date possible after the lapse in appropriations 

2 ends, regardless of scheduled pay dates. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
Order entered August 23 , 2016

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 16

- 00764

- CR

JACOBY TAYLOR, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 195th Judic ial District Court

Dallas County, Texas Trial Court Cause No. F07

- 52952

- N



### O RDER

The Court ORDERS the trial court to make findings of fact regarding whether appellant

has been deprived of the reporter’s record because of ineffective counsel, indigence, o r for any

other reason.

 The trial court shall first determine whether appellant desires to prosecute the appeal. If the trial court determines that appellant does not desire to prosecute the appeal, it shall make a finding to that effect.

 If the trial co urt determines that appellant desires to prosecute the appeal, it shall next determine whether appellant is indigent and entitled to proceed without payment of costs for the reporter’s record. If appellant is entitled to proceed without payment of costs, the trial court shall make a finding to that effect. Moreover, if appellant is indigent, the trial court is ORDERED to take such measures as may be necessary to assure effective representation, which may include appointment of new counsel. If the trial c ourt finds appellant is not indigent, it shall determine whether retained counsel has abandoned the appeal. The trial court shall next determine: (1) the name and address of each court reporter who

recorded the proceedings in this cause; (2) the court re porter’s explanation for the delay in filing the reporter’s record; and (3) the earliest date by which the reporter’s record can be filed.

We ORDER the trial court to transmit a record, containing the written findings of fact,
any supporting documentatio n, and any orders, to this Court within THIRTY DAYS of the date

of this order.
The appeal is ABATED to allow the trial court to comply with this order. The appeal
shall be reinstated thirty days from the date of this order or when the findings are receive d,

whichever is earlier.

/s/ LANA MYERS JUSTICE
<PAGE>

                                                                    Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report on Form 10-Q of Aspect Medical
Systems, Inc. (the "Company") for the period ended October 2, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, Nassib G. Chamoun, Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. Section 1350, that:

         (1)      the Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

Dated: November 10, 2004                   /s/ Nassib G. Chamoun
                                           --------------------------------
                                           Nassib G. Chamoun
                                           Chief Executive Officer

         A signed original of this written statement required by Section 906 has
been provided to Aspect Medical Systems, Inc. and will be retained by Aspect
Medical Systems, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
Exhibit 10.1







Exhibit 10.1




FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT




This Fourth Amendment to Executive Employment Agreement (this “Amendment”) is entered into by and between American
Reprographics Company, a Delaware corporation (“ARC”) as the employer, and Kumarakulasingam Suriyakumar, an individual
residing in the State of California (“Executive”), as the employee, on March 11, 2009.



This Amendment is entered into with reference to the following facts:



ARC and Executive entered into an Executive Employment Agreement dated January 7, 2005, as amended (“Agreement”),
under which Executive is employed as Chief Executive Officer and President of ARC. The parties now wish to enter into
this Amendment to amend the Agreement.



Now, therefore, the parties agree as follows:



1. All capitalized terms in this Amendment not otherwise defined herein shall have the meanings ascribed to them
in the Agreement.



2. A new Section 3(a)(i) is added to Section 3(a) of the Agreement (Base Salary) as follows:




“(i) Executive agrees to a voluntary reduction in the amount of base salary payable to Executive
pursuant to Section 3(a) shall be reduced by fifty percent (50%) (the “Base Salary Reduction”)
effective as of March 7, 2009 until modified through further amendment of this Agreement (the
“Effective Period”). Notwithstanding anything to the contrary contained in this Section 3(a)(i), if
Executive’s employment with ARC is terminated other than for Cause during the Effective Period, any
Base Salary severance benefits payable to Executive under Sections 12(a), (c) or (d) of the Agreement
shall be calculated based on the amount of Base Salary set forth in Section 3(a), without taking into
account the Base Salary Reduction.”



3. A new Section 3(b)(v) is added to Section 3(b) of the Agreement (Incentive Bonus) as follows:




“(v) Notwithstanding anything to the contrary contained in this Section 3(b), Executive waives any
Incentive Bonus that may be earned by Executive for the fiscal year ending December 31, 2009 and
payable during the fiscal year ending December 31, 2010.”



4. Except as specifically set forth in this Amendment, the Agreement remains in full force and effect without
modification.


 


1









 





IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date first hereinabove set forth.




AMERICAN REPROGRAPHICS COMPANY, 
a Delaware corporation




By: /s/ Jonathan R. Mather

Name: Jonathan R. Mather

Title: Chief Financial Officer





EXECUTIVE




/s/ Kumarakulasingam Suriyakumar
Kumarakulasingam Suriyakumar




2

 


2
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of NATIONAL TECHNICAL SYSTEMS, INC. (the "Company") on Form 10-K for the
period ending January 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William McGinnis, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge:



Dated: April 30, 2009



/s/ WILLIAM MCGINNIS William McGinnis, Chief Executive Officer
(Principal Executive Officer)


A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.

---



QuickLinks
<PAGE>
                                                                    Exhibit 32.1



               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report on Form 10-Q of Aspect Medical
Systems, Inc.(the "Company") for the period ended July 3, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, Nassib G. Chamoun, Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. Section 1350, that:

       (1)  the Report fully complies with the requirements of Section 13(a)or
            15(d) of the Securities Exchange Act of 1934; and

       (2)  the information contained in the Report fairly presents, in all
            material respects,  the financial condition and results of
            operations of the Company.




                                                         /s/ Nassib G. Chamoun
                                                         ----------------------
Dated:  August 11, 2004                                  Nassib G. Chamoun
                                                         Chief Executive Officer



     A signed original of this written statement required by Section 906 has
been provided to Aspect Medical Systems, Inc. and will be retained by Aspect
Medical Systems, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.